301033.SZ Stock Analysis
30
Uncovered
Medprin Regenerative Medical Technologies Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Medprin Regenerative Medical Technologies Co. Ltd. engages in the development of implanted medical devices. The company is headquartered in Guangzhou, Guangdong and currently employs 271 full-time employees. The company went IPO on 2021-07-26. The firm's implanted medical device products include artificial dura mater (spine) patch, cranio-maxillofacial repair products and absorbable hemostatic yarns. 3D printing equipment includes biological 3D printers, resin 3D printers and other related supporting components. Technical services include general technical services and scientific research services. The firm distributes its products both in the domestic market and to overseas markets.